Immatics at CHI’s 4th Annual Cancer Immunotherapy Executive Summit (March 11-13) in San Francisco, CA

| News, USA

Immatics will be at the Cancer Immunotherapy Executive Summit (March 11-13) in San Francisco, CA! If you’re interested in Immatics updates don’t miss out to approach us on-site and to join in on Steffen Walter’s (CSO Immatics US) talk:

 

March 13th, 4pm - 4.15pm

Talk: "TCR-Based Therapies for Solid Tumors Using Novel Antigens"

 

We’re looking forward to interesting and exciting discussions.

Further information on CHI’s 4th Annual Cancer Immunotherapy Executive Summit here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back